A variety of inositol phosphates including <i>myo</i>-inositol 1,4,5-trisphosphate, which is a secondary messenger in transmembrane signaling, were selectively synthesized via Yb(OTf)<sub>3</sub>-catalyzed desymmetrization of <i>myo</i>-inositol 1,3,5-orthoformate using a proline-based chiral anhydride as an acylation precursor. The investigated catalytic system could regioselectively differentiate the enantiotopic hydroxy groups of <i>myo</i>-inositol 1,3,5-orthoformate in the presence of a chiral auxiliary. This key step to generate a suitably protected chiral <i>myo</i>-inositol derivatives is described here as a unified approach to access inositol phosphates
The design of a range of 4-position-modified D-myo-inositol 1,4,5-trisphosphate derivatives is descr...
Homochiral myo-inositol derivatives 16 and 20 and their corresponding enantiomers possessing either ...
Desymmetrization by phosphorylation represents a promising method with potential impact in many diff...
A variety of inositol phosphates including <i>myo</i>-inositol 1,4,5-trisphosphate, which is a secon...
Orthogonally protected chiral <i>myo-</i>inositol derivatives are important intermediates for higher...
Many naturally occurring inositol derivatives are fundamental regulators of signalling, metabolism, ...
Acid hydrolysis of <i>myo</i>-inositol 1,3,5-orthoesters, apart from orthoformates, exclusively affo...
ABSTRACT: Acid hydrolysis of myo-inositol 1,3,5-orthoesters, apart from orthoformates, exclusively a...
D- and L- chiro-inositols are readily and inexpensively available as their O-methyl ethers pinitol a...
[[sponsorship]]基因體研究中心,生物化學研究所[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/g...
Racemic 4-<i>O</i>-allyl-<i>myo</i>-inositol-1,3,5-orthoesters were resolved as the corresponding di...
Target of the present work is the development of a new synthetic methodology towards the synthesis o...
Racemic myo-inositol-1,4,5-trisphosphate and myo-inositol-1,4-bisphosphate, which are respectively a...
Homochiral myo-inositol derivatives 16 and 20 and their corresponding enantiomers possessing either ...
Homochiral myo-inositol derivatives 16 and 20 and their corresponding enantiomers possessing either ...
The design of a range of 4-position-modified D-myo-inositol 1,4,5-trisphosphate derivatives is descr...
Homochiral myo-inositol derivatives 16 and 20 and their corresponding enantiomers possessing either ...
Desymmetrization by phosphorylation represents a promising method with potential impact in many diff...
A variety of inositol phosphates including <i>myo</i>-inositol 1,4,5-trisphosphate, which is a secon...
Orthogonally protected chiral <i>myo-</i>inositol derivatives are important intermediates for higher...
Many naturally occurring inositol derivatives are fundamental regulators of signalling, metabolism, ...
Acid hydrolysis of <i>myo</i>-inositol 1,3,5-orthoesters, apart from orthoformates, exclusively affo...
ABSTRACT: Acid hydrolysis of myo-inositol 1,3,5-orthoesters, apart from orthoformates, exclusively a...
D- and L- chiro-inositols are readily and inexpensively available as their O-methyl ethers pinitol a...
[[sponsorship]]基因體研究中心,生物化學研究所[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/g...
Racemic 4-<i>O</i>-allyl-<i>myo</i>-inositol-1,3,5-orthoesters were resolved as the corresponding di...
Target of the present work is the development of a new synthetic methodology towards the synthesis o...
Racemic myo-inositol-1,4,5-trisphosphate and myo-inositol-1,4-bisphosphate, which are respectively a...
Homochiral myo-inositol derivatives 16 and 20 and their corresponding enantiomers possessing either ...
Homochiral myo-inositol derivatives 16 and 20 and their corresponding enantiomers possessing either ...
The design of a range of 4-position-modified D-myo-inositol 1,4,5-trisphosphate derivatives is descr...
Homochiral myo-inositol derivatives 16 and 20 and their corresponding enantiomers possessing either ...
Desymmetrization by phosphorylation represents a promising method with potential impact in many diff...